Global Antibiotic R&D Partnership (GARDP)
Tammy (Thameshnee) Pillay serves as the Head of Global Regulatory Affairs at the Global Antibiotic R&D Partnership (GARDP) since March 2023, leading the development and implementation of regulatory strategies for the organization's portfolio. Previously, Tammy held the position of Chairperson at the Southern African Pharmaceutical Regulatory Affairs Association from April 2019 to May 2023 and worked as a Responsible Pharmacist at Viatris from July 2020 to February 2023. Additional experience includes roles as a Consultant at HUMSA Pharma Consulting and as the Director of Regulatory Affairs/Responsible Pharmacist at Gilead Sciences. Tammy holds a Master of Project Management from the University of Southern Queensland and a Bachelor of Pharmacy from the University of KwaZulu-Natal, along with participating in the ORAQ Training Program at Duke University School of Medicine in 2023.
This person is not in any teams
This person is not in any offices
Global Antibiotic R&D Partnership (GARDP)
The Global Antibiotic Research & Development Partnership (GARDP) is a not-for-profit organization that develops new antibiotic treatments for drug-resistant bacterial infections that pose the greatest threat to human health, and makes them accessible to the people who need them. It puts public health needs at the centre of antibiotic drug development to address both the immediate antimicrobial resistance (AMR) crisis and to ensure people continue to get access to essential antibiotics for generations to come. GARDP works through a global network including Brazil, India, Japan, and South Africa for antibiotic development and access. Its work is made possible by essential funding from donors and collaboration with over 100 R&D and access partners in over 20 countries. GARDP was created by the World Health Organization and the Drugs for Neglected Diseases initiative (DNDi) in 2016 and legally registered as the GARDP Foundation in Geneva, Switzerland in 2018. www.gardp.org